SpectraCure AB (publ) (STO:SPEC)
Sweden · Delayed Price · Currency is SEK 0.0237
-0.0002 (-0.84%)
Sep 4, 2026, 5:23 PM CET
SpectraCure AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7.63 | 13.53 | 18.27 | 56.95 | 93.18 | 129.69 |
Cash & Short-Term Investments | 7.63 | 13.53 | 18.27 | 56.95 | 93.18 | 129.69 |
Cash Growth | -17.48% | -25.99% | -67.91% | -38.88% | -28.15% | -17.52% |
Accounts Receivable | 0.28 | 0.6 | 0.33 | 0.18 | 0.15 | 0.19 |
Other Receivables | 1.07 | 1.96 | 3.51 | 1.62 | 1.02 | 0.91 |
Receivables | 1.35 | 2.56 | 3.84 | 1.8 | 1.16 | 1.1 |
Prepaid Expenses | 1.03 | 0.11 | 0.14 | - | - | - |
Other Current Assets | 0 | 0.04 | - | - | - | - |
Total Current Assets | 10.02 | 16.22 | 22.25 | 58.75 | 94.34 | 130.8 |
Property, Plant & Equipment | 9.46 | 3.05 | 5.4 | 6.95 | 3.96 | 6.18 |
Long-Term Investments | - | - | - | 0.69 | 1.23 | - |
Other Intangible Assets | 1.86 | 1.64 | 1.38 | 1.23 | 1.19 | 1.19 |
Long-Term Deferred Tax Assets | - | - | 0.01 | 0.02 | 0.02 | 0.02 |
Long-Term Deferred Charges | 91.19 | 83.56 | 91.97 | 77.19 | 61.68 | 52.34 |
Total Assets | 112.52 | 104.47 | 121 | 144.83 | 162.42 | 190.52 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.7 | 1.71 | 3.32 | 1.04 | 1.61 | 1.83 |
Accrued Expenses | 7.73 | 6 | 5.47 | 2.37 | 3.09 | 3.06 |
Current Portion of Leases | 2.69 | 2.57 | 2.54 | 2.32 | 2.43 | 2.41 |
Current Unearned Revenue | - | 0.17 | 0.05 | 0.58 | 1.22 | 1.96 |
Other Current Liabilities | 0.59 | 0.22 | 0.17 | 4.28 | 3.5 | 3.09 |
Total Current Liabilities | 12.71 | 10.67 | 11.54 | 10.58 | 11.85 | 12.35 |
Long-Term Leases | 6.22 | 0.22 | 2.6 | 4.4 | 0.27 | 2.49 |
Long-Term Deferred Tax Liabilities | 0.01 | 0.03 | - | - | - | - |
Total Liabilities | 18.94 | 10.92 | 14.15 | 14.98 | 12.12 | 14.84 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 57.06 | 40.97 | 9.71 | 9.71 | 9.71 | 9.71 |
Additional Paid-In Capital | 264.94 | 268.03 | 258.01 | 258.01 | 258.01 | 258.01 |
Retained Earnings | -228.42 | -215.45 | -160.87 | -137.87 | -117.43 | -92.05 |
Shareholders' Equity | 93.58 | 93.55 | 106.86 | 129.86 | 150.3 | 175.68 |
Total Liabilities & Equity | 112.52 | 104.47 | 121 | 144.83 | 162.42 | 190.52 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 8.91 | 2.79 | 5.15 | 6.72 | 2.7 | 4.9 |
Net Cash (Debt) | -1.28 | 10.74 | 13.13 | 50.23 | 90.48 | 124.79 |
Net Cash Growth | - | -18.23% | -73.86% | -44.48% | -27.49% | -17.84% |
Net Cash Per Share | -0.00 | 0.04 | 0.14 | 0.52 | 0.93 | 1.28 |
Filing Date Shares Outstanding | 682.8 | 409.67 | 97.13 | 97.13 | 97.13 | 97.13 |
Total Common Shares Outstanding | 682.8 | 409.67 | 97.13 | 97.13 | 97.13 | 97.13 |
Working Capital | -2.69 | 5.55 | 10.7 | 48.17 | 82.49 | 118.44 |
Book Value Per Share | 0.14 | 0.23 | 1.10 | 1.34 | 1.55 | 1.81 |
Tangible Book Value | 91.72 | 91.91 | 105.48 | 128.63 | 149.11 | 174.49 |
Tangible Book Value Per Share | 0.13 | 0.22 | 1.09 | 1.32 | 1.54 | 1.80 |
Machinery | - | 1.73 | 1.86 | - | - | - |